A phase II, multicenter, single-arm study of MPDL3280A in patients with advanced PD-L1_positive Locally advanced or Metastatic non-small cell lung cancer.
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Start Date
October 1, 2013
End Date
August 8, 2018
Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Start Date
October 1, 2013
End Date
August 8, 2018